#meanwhile endogenics have continued to use the term
Explore tagged Tumblr posts
Text
clears throat ahem. ahem ahem. IF YOU ARE ANTI ENDO. STOP. FUCKING. USING. THE. TERM. ALTERHUMAN. AND. ALTERHUMAN. TAGS.
THIS IS /SRS.
Pulls down whiteboard with red strings and frantic push pinned images. Alterhuman was coined with endogenic systems in mind. ALL origins of plurality are included in the definition of Alterhuman (By this I mean nonhuman alters being allowed to consider themselves alterhuman if they wish) so if you're going to be an ALTERHUMAN and be VICIOUSLY anti-endo ESPECIALLY when you're a singlet than stop. fucking using the term. it wasn't made for you hateful bigots. There are other terms for you. Stop bullying endogenic systems who are using terms made for them.
Source (this is the coining post for the term alterhuman. It specifically mentions plural, median, and walk in identities; if you don't believe me, here's a link to the coiner of alterhuman being explicitly pro endo; and here's a link to the coiner saying this account belongs to them.)
74 notes · View notes
antiendovents · 1 year ago
Note
What's hysterical (/sarcastic) about this Sophie thing is she's clearly got a weird persecution fantasy, continuously going on and on about "marginalized groups" referring to endos as if systems are some kind of oppressor class, meanwhile in the real world we're the ones who are demonized and stigmatized, who lose jobs and homes and friends and partners because of an uncontrollable trauma disorder. And it's baffling to me how she doesnt understand that intentionally invading the spaces of disordered people as someone whos alleged plurality is nondisordered and healthy makes her a bad person. It's like if I as an able bodied person went to a paraplegic support group and started saying they're bigoted for excluding me because I experience sitting down too, and that id turn their friends and families against them for it. That would be batshit, she'd immediately be shunned for rampant and overt ableism, and it's basically the same thing.
(note in case of confusing word formatting: I don't say "traumagenic" to refer to systems, but do say endogenic to refer to endos. it's silly to treat the two concepts as if they have equal validity by using fancy sounding made up matching terms, endos can have their silly word, and systems can be systems.)
yeah,, she acts as if endos are oppressed but in reality they are part of the problem, they are the ones who are contributing to the oppression and persecution of actual systems. They will never understand the struggle of being an actual system, but they act like they do. They act like they're suddenly a victim because they.. aren't traumatized? What??? It makes no sense.
37 notes · View notes
justanothersyscourse · 3 years ago
Text
So apparently none of these things are up for debate because no one can reblog or comment
Nice
@amaranthis
Go ahead, "make an example out of me," but only after I make one of you.
First, I swear to god, the only ones making #miserablyDID a thing are people like you. What people like me are trying to tell people like you is that dysfunction is a fluctuating label, and the DSM entry for DID explains that dysfunction can be minimal to non-existent and you can still be disordered, and that's okay.
Disordered isn't a bad word and it's not synonymous with dysfunction, and the DSM explains why and how.
You just don't want to listen and instead continue to spread the idea that you have be miserable and struggling every day if you're disordered. As if people don't live fulfilling, happy lives with all kinds of disorders.
No, DID is definitely the exception, right?
You ignore that the DSM allows for someone to reach final fusion and still have DID based on their ability to split later in life.
You ignore that the DSM explains that a disorder doesn't mean need for treatment, and you silence and hide voices trying to explain that under the guise of protecting endogenics from "hate", meanwhile, the misinformation you're pushing is actively harmful to DID systems.
You ignore when we explain that the DSM states that you can be trans without dysphoria, and that in most cases, dysfunction in that case comes from failures on the side of medical practitioners and deniers. Transmeds go against the DSM and current research, and comparing syscourse to that is hugely dismissive of the fight trans people have fought.
In terms of DID/OSDD, the DSM explains that it IS a trauma-based disorder, but no one bothers to read beyond the criteria (which also mentions trauma? The and/or doesn't mean trauma is optional, but go off I guess). Sysmeds support the DSM and current research.
The fight isn't comparable, and you're basically denying science and history at this point in favour of an argument that doesn't actually apply.
You ignore the very real damage that IFS has done to the treatment of DID/OSDD, and you ignore our concerns when we say we see the same things coming with endogenics if the language used isn't changed and the line clearly separated.
You ignore that we have answers to all of those questions you asked in the tags. We know why and how the cut off age works, and how autism can increase that age to about 12. From the writers of the DSM.
Tumblr media
In b4 hypothesized, because we can see it now, and the DSM 5 TR has been updated to reflect this new understanding.
You ignore that we already understand how and why those with DID have alters and how trauma plays into that.
You ignore that this means that: those biomarkers, or injuries = DID/OSDD, and that if someone is apparently a system without those injuries, it is completely, 100% different. How can it not be? Those injuries affect every aspect of our lives-- the way we retain, recall, and manage memories and information, our emotional reactions to things. Someone without them isn't going to understand it, but people like you demonize people like me for pointing that out, despite the fact that it's kind of obvious when you think about it.
You ignore that the DSM is quite clear about what kind of cultural experiences are excluded and why and how, and it's not for teens on tumblr, and saying it is, is denying the long, hard fight to keep spiritual and religious practices out of the DSM, because they're not the same things.
We already have the answers, you just don't like them, and you just proved on this post that you don't actually care about education, you care about silencing people who disagree and try to point out that you're misreading and misunderstanding things.
64 notes · View notes
preefacto · 6 years ago
Text
APEJ to Remain Most Remunerative Market for Peptide and Heparin
Although therapeutic peptides were originally developed for replacing their endogenous lack, spectrum of the candidate peptide drugs available is not by far restrained to human peptide pool. With the help of multifarious organisms, bioactive peptides are being discovered through modern tools of peptidomics. A virtually infinite range of potential peptide-based medications await pharmacological characterization. Meanwhile, several methods of peptide synthesis are evolving to enable highly efficient production of extraordinarily long & heavily-modified compounds. Numerous clinical trials associated with peptide drug candidates are currently being conducted, which in turn represents a bright future for peptide-based therapeutics. Vendors of peptide therapeutics have been moving to developing countries on the back of large population base serving as potential clinical subjects. Lenient regulatory guidelines, skilled labor, low manufacturing costs, and low market competition are primary reasons why vendors of peptide therapeutics are outsourcing their manufacturing processes to these countries.
Read Report Summary: https://www.factmr.com/report/378/peptides-heparin-market The market for heparin will continue to be influenced by increasing prevalence of diseases, which lead to formation of clots. Concerns regarding adulteration had been the cause for the prohibition of bovine heparin by the U.S. FDA. However, extreme shortage of porcine heparin has led the FDA to reconsider introduction of bovine heparin, which in turn has led to a rise in amount of crude heparin. Heparin is increasingly used prior to surgeries, during blood transfusion or dialysis, when blood is collected as a sample, which implies their general use for reducing the blood clotting risk. Apart from surgical applications, heparin is also prescribed for preventing blood clot in patients affected with chest pain or angina. Heparin’s supply chain commences at slaughterhouses, trailed by various workshops that extract basic heparin material, called heparin crude, from the mucous membrane of pig intestine. Heparin crude is then sold to pharmaceutical companies, which post-processing produce heparin. According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The peptide and heparin market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.
Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=378 Hospital pharmacies are expected to remain the dominant distribution channel for peptide and heparin. Revenues from sales of peptide and heparin in hospital pharmacies are anticipated to remain considerably larger than those from retail pharmacies and online pharmacies combined. On the basis of indication, revenues from sales of peptide and heparin for cancer treatment are projected to account for the largest market share by 2026-end. Cardiovascular and metabolic disorder indication will also remain remunerative in the market. Sales of peptide and heparin for central nervous systems indication are expected to register the fastest expansion through 2026. Liraglutide is expected to remain the most lucrative product in the market, followed by bortezomib and goserelin. Liraglutide sales will exhibit the highest CAGR through 2026. In addition, sales of sodium heparin, lithium heparin and exenatide are projected to register a parallel growth through 2026. Asia-Pacific excluding Japan (APEJ) will continue to be the largest market for peptide and heparin, in terms of revenues. The markets in Europe and North America will also remain lucrative, however revenues from these regions will remain significantly lower than those from APEJ. Key market participants identified by the report include Eli Lilly, Novo Nordisk, Sanofi, Takeda, Teva, Leo Pharma, Aspen, Pfizer Inc., Abbott Laboratories, Bachem, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., AmbioPharm, Inc., Hemmo Pharma, Biofer S.p.A, Celsus, and Baxter.
For a detailed industry outlook, Get the Report Sample at: https://www.factmr.com/connectus/sample?flag=S&rep_id=378
About Us Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates. Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data. The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for. Contact Us 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States E: [email protected] Blog: https://theheraldmedia.com/
0 notes
sramfact · 6 years ago
Text
Peptides and Heparin Market to Witness an Outstanding Growth by 2026
According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The peptide and heparin market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.
Vendors of Peptide Therapeutics are Outsourcing Manufacturing Processes to Developing Countries
Although therapeutic peptides were originally developed for replacing their endogenous lack, spectrum of the candidate peptide drugs available is not by far restrained to human peptide pool. With the help of multifarious organisms, bioactive peptides are being discovered through modern tools of peptidomics. A virtually infinite range of potential peptide-based medications await pharmacological characterization. Meanwhile, several methods of peptide synthesis are evolving to enable highly efficient production of extraordinarily long & heavily-modified compounds. Numerous clinical trials associated with peptide drug candidates are currently being conducted, which in turn represents a bright future for peptide-based therapeutics. Vendors of peptide therapeutics have been moving to developing countries on the back of large population base serving as potential clinical subjects. Lenient regulatory guidelines, skilled labor, low manufacturing costs, and low market competition are primary reasons why vendors of peptide therapeutics are outsourcing their manufacturing processes to these countries.
Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=378
The market for heparin will continue to be influenced by increasing prevalence of diseases, which lead to formation of clots. Concerns regarding adulteration had been the cause for the prohibition of bovine heparin by the U.S. FDA. However, extreme shortage of porcine heparin has led the FDA to reconsider introduction of bovine heparin, which in turn has led to a rise in amount of crude heparin. Heparin is increasingly used prior to surgeries, during blood transfusion or dialysis, when blood is collected as a sample, which implies their general use for reducing the blood clotting risk. Apart from surgical applications, heparin is also prescribed for preventing blood clot in patients affected with chest pain or angina. Heparin’s supply chain commences at slaughterhouses, trailed by various workshops that extract basic heparin material, called heparin crude, from the mucous membrane of pig intestine. Heparin crude is then sold to pharmaceutical companies, which post-processing produce heparin.
6 Key Future Prospects of Peptide and Heparin Market for Forecast Period 2017-2026
Hospital pharmacies are expected to remain the dominant distribution channel for peptide and heparin. Revenues from sales of peptide and heparin in hospital pharmacies are anticipated to remain considerably larger than those from retail pharmacies and online pharmacies combined.
On the basis of indication, revenues from sales of peptide and heparin for cancer treatment are projected to account for the largest market share by 2026-end. Cardiovascular and metabolic disorder indication will also remain remunerative in the market. Sales of peptide and heparin for central nervous systems indication are expected to register the fastest expansion through 2026.
Oral route of administration will remain preferred for peptide and heparin, with revenues estimated to surpass US$ 15,000 Mn by 2026-end. However, sales of peptide and heparin with intravenous route of administration will register a comparatively faster growth through 2026.
Liraglutide is expected to remain the most lucrative product in the market, followed by bortezomib and goserelin. Liraglutide sales will exhibit the highest CAGR through 2026. In addition, sales of sodium heparin, lithium heparin and exenatide are projected to register a parallel growth through 2026.
Asia-Pacific excluding Japan (APEJ) will continue to be the largest market for peptide and heparin, in terms of revenues. The markets in Europe and North America will also remain lucrative, however revenues from these regions will remain significantly lower than those from APEJ.
Need more Information about Report Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=378
Key market participants identified by the report include Eli Lilly, Novo Nordisk, Sanofi, Takeda, Teva, Leo Pharma, Aspen, Pfizer Inc., Abbott Laboratories, Bachem, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., AmbioPharm, Inc., Hemmo Pharma, Biofer S.p.A, Celsus, and Baxter.
0 notes
womensdiary-blog · 8 years ago
Text
Obesity And Its 6 Harmful Effects On The Body
New Post has been published on https://womensdiary.com/obesity-and-its-6-harmful-effects-on-the-body.html
Obesity And Its 6 Harmful Effects On The Body
Obesity And Its 6 Harmful Effects On The Body
The main causes of obesity are genetic factors, the influence of society, cultural, environmental and economic factors. Obesity appears in the context of a positive unbalance between the quantity of calories intake and the quantity of energy submitted by the individual.
The following causes of obesity are in the order of frequency and importance:
Food abuse or overeating.
Sedentariness or reducing of lack of physical activity, in relation to unchanged diet.
Internet, lack of sleeping and alcohol
Physical trauma or psychological factors, meaning that people tend to consume more food in order to get satisfied, when they have failures, emotional disappointments, repressions.
Genetic and congenital factors.
Endocrine factors.
Food abuse or overeating
This is one of the main causes of obesity. External factor, most often it is difficult to determine accurately the history of overweight people. They either underestimate consciously their diet, or they are intentionally independent of this parameter of nutrition, considering that “every man eats as much as he is hungry”. The tendency of overeating may miss when weight gain process triggers, leading to obesity ultimately.
The first step towards obesity is called “dynamic phase”, during which the individual increases caloric intake and gains weight. During the second step, “static phase”, obesity does not make any progress, being maintained with a relatively moderate caloric intake. Overeating as external factor and one of the causes of obesity, so perfect within our reach for control and surveillance, through preventing means which depend on diet and lifestyle, is on the first position of more than 90% of obesity cases. However, the main external causes of obesity, overeating and sedentariness, do not represent most of the obesity cases, but only collateral phenomena, which are associated with cortical and diencephalic disorders, thus being an internal factor.
On the other hand, external causes of obesity usually lead to endocrine andcauses of obesity metabolic disorders, having a role in further development of obesity. Thus, external factors, dominated by overeating, combined with internal factors, constitute a powerful combination of causes of obesity difficult to separate. In order to overcome food abuse, obese people should consult with a nutritionist to set an obesity treatment or weight loss plan customized according to their needs. The doctor can prescribe also weight loss supplements that suppress appetite and boost metabolism in order to lose weight faster. The best weight loss supplements are those that contain natural ingredients and extracts.
 Sedentariness
There are many factors of causes-of-obesity-s sedentariness seen as causes of obesity:
– Reducing physical activity when aging.
– The tendency of people to watch TV for long periods of time.
– The habit of replacing regular meals with unhealthy snacks, fast-food rich in calories.
– Alcohol and carbonated juices.
All these lead to obesity, especially when people get from a younger age to maturity. Sedentary jobs, giving up sport, commodity, travelling by car instead of walking or cycling are among the most common causes of obesity. The role of sedentariness occurs especially from the analysis of jobs. 80,9% of the obese people have sedentary jobs, among which: at home 39,90%, sedentary workers 16,22%, public clerks 14,30%, retired 10,48%. On the other hand, active workers were only 10,8% among obese people. This analysis highlights the effect of environmental factor as one of the causes of obesity. Therefore, unbalanced diet and reducing physical activity are the main causes of obesity.
Internet, lack of sleeping and alcohol
Women and young girls that spend almost of theirthe obesity internet time on the Internet, do not sleep enough or consume alcohol regularly are more prone to gain weight than other active people. The more time they spend on Internet, the more body weight increases, it is a conclusion reached by some US researchers after a study performed on 5036 girls aged between 14 and 21 years. In most of the studied cases, researchers have discovered than the more time they spend on Internet, the same thing happens with body mass, especially for girls around 18 years old.
The specialists have noticed the same consequences on weight due to regular consumption of alcohol and lack of sleeping. As for sleeping, the specialists have noticed that girls who have slept 5 hours or less during night have gained weight, unlike those who have slept 8 hours. Girls who have consumed two or more alcoholic drinks in a week have gained weight, and those who have consumed smaller quantities have maintained their weight.
The effects of time spent on Internet, lack of sleeping and alcohol can be relatively unimportant on a short period of time. But, on long terms, gaining weight will become more serious. Specialists say that lack of sleeping affects the hormones and metabolism, which favours the development of obesity and alcohol contains high levels of calories. These three causes of obesity are among the ones that affect young people all over the world.
 Physical trauma or psychological factors
It is said that these factors are causes of obesity for 5,4% of overweight women and 3,4% of overweight men. Accumulation of adipose tissue occurs as a result of physical trauma, which disturbs the mental balance and triggers depression. Meanwhile, nervous pressure which accumulates, disrupts the endocrine activity of the body. Psychological causes of obesity include, on the one hand a number of constraints imposed by the individual and also the presence of disturbing emotional feelings.
Some people continue to be obese due to compulsive eating even after the end of the diet plan. Because a diet plan represents a conscious constraint, the collapse of conscious constraint is one of the factors that the intake of calories increases. There are people who consciously manage their food consumption and people who cannot do this. Regardless of their actual weight, eating habits of people who restrict food intake is more similar to the habit of overweight people than people who eat without restrictions.
People who try to eat less and ignore the impulse of hunger may get to the point when they can ignore even satiety, thing that will normally stop their hunger. Overweight people sometimes say that they tend to eat more when they are nervous and anxious. Often times, because of high levels of stress and anxiety people eat more than in a low level of anxiety. For obese people, any type of emotion can increase the food intake.
Genetic and congenital factors
Genetic factors, seen as causes of obesity, seem the play a very important role, but not necessary a decisive part. It is well known that in families with obese people the risk of obesity is very high. If one of the parents is obese, there are 50% chances that children will become obese too. If both parents are obese, the child has 80% chances to suffer from obesity.
The influence of genes is mediated by their effect on fat cells, metabolic rate and homeostatic values. The bodies of some people tend to turn to a greater proportion of calories in fat deposits, while for others, the body burns this amount of extra calories in different metabolic processes, no matter how much they eat.
Congenital causes of obesity affect the fetüs during mother’s pregnancy. Over 40% of 753 obese people have direct descendants suffering from obesity, and another study performed on 1000 obese people have shown that obesity appeared to collateral or direct ascendants for almost 70% of the cases. The weight of obese women’s babies is connected to obesity. It can be said that hereditary predisposition to obesity can be aggravated by some factors which affect the fetus during uterine life or at birth.
 Endocrine causes of obesity
Obesity may occur in the context of endocrine changes or in the context of neurological diseases. Endogenous causes of obesity such as: pregnancy, Cushing syndrome, adipose – genital syndrome etc. are not that frequent. Primary and direct role of endocrine glands in the development of obesity is becoming more contested. Obesity seems as a false disease of the glands, because endocrine disorders sometimes represent the effects and not the causes of obesity.
Obesity can be defined as a 20% weight excess over the theoretical weight, specifying that excess weight consists in fat deposit. Theoretically there is a risk of confusion between obesity and water retention. Practically, such a confusion is hard to make because the clinic aspect cannot make mistakes. Normal weight can vary between some limits.
Overweight problems are easy to treat. All you need is a little patience and to follow some easy steps. First you should do a detox of the body, and combine a healthy diet with weight loss supplements that contain natural ingredients and soon you will see positive effects.
What do you have to lose if you start losing weight now?
0 notes
medicalmarijuana-news · 8 years ago
Text
Vitamin THC: Cannabis as a Superfood
Is marijuana a superfood? Should cannabinoids be considered essential nutrients? And if so, why are so many edibles still sugar-laden sweets? To find out, we tracked down a few infused-food professionals focused on transforming the herb into fuel for a healthy, vital lifestyle.
In 1753, a Scottish surgeon by the name of James Lind proved that scurvy could be effectively cured with citrus juice. By drinking plenty of lemonade over the course of a two-week long treatment, his patients would fully recover from the fatigue, sores and bleeding typically inflicted by this malady, which was formerly thought to be caused by poor digestion and unclean water (when the real culprit was a simple deficiency in vitamin C).
Until that discovery, the debilitating and often fatal disease limited the ability of seafaring vessels to travel long distances. But after Lind’s popularization of a cure, sailors learned to effectively prevent scurvy by packing barrels of lemon juice and fresh limes for their travels. Today, the disease is so rare as to be almost unheard of, but British sailors retain the nickname limeys, which dates back to their adoption of the practice.
Meanwhile, often derided as a marketing term without scientific basis, the label “superfood” indeed has no legal definition, but according to the Macmillan Dictionary it can be applied to any food that’s “considered to be very good for your health and that may even help some medical conditions.” And so, because vitamin C is found in large quantities in citrus fruits—oranges, lemons and limes can be considered superfoods.
You are what you eat, after all, and foods like kale, sweet potatoes, blueberries and wild salmon provide essential macro- and micro-nutrients that the human body requires for health. Superfoods confer increased vitality and allow humans to fully thrive, along with preventing or treating diseases.
For example, broccoli has widely touted anti-cancer properties, while salmon provides Omega-3 fatty acids that protect your heart, and blueberries arrive packed with antioxidants and phytoflavinoids that prevent inflammation and can help prevent cancer and heart disease.
Include cannabis as part of diet rich in superfoods. (Photo by Damion Lloyd)
Now imagine that all around the world, millions of people are suffering from a modern-day version of scurvy—that is, an easily treatable condition caused by a lack of essential nutrition. Only in this case, the missing dietary element is cannabis, or more specifically cannabinoids, a set of incredibly medicinal compounds found primarily in the marijuana plant.
All humans have what’s called an endocannabinoid system, comprised of receptors that fit these cannabinoids like a lock fits a key, and this endocannabinoid system regulates many vital systems in the body—including respiratory, circulatory and neurological. Which means, if that system malfunctions and cannabinoids are not brought into the body from the outside (by smoking/vaping/eating cannabis) to return it to balance, the negative consequences can be severe, or even life-threatening.
Dr. Ethan Russo first articulated this idea of “clinical endocannabinoid deficiency” (CECD) in a 2004 scientific paper, describing a condition that contributes to high levels of cancer and degenerative diseases,inflain such as Alzheimer’s, inflammatory bowel disease, multiple sclerosis, Parkinson’s and rheumatoid arthritis. With the research to back it up, he’s basically claiming that a lack of cannabis can be the underlying cause of these and many other potentially deadly conditions.
Now imagine that the preventative cure for all of these painful, heartbreaking outcomes could lie in the cannabis plant being widely used as a dietary supplement, much as lemons and limes ended scurvy over two hundred years ago.
After all, if CECD is caused when the body doesn’t produce enough endocannabinoids on its own, and this lack of endogenous cannabinoids can be corrected by adding cannabis from herbal sources, such a simple dietary supplement could save untold lives and relieve immeasurable suffering.
And so, much like James Lind and his studies into the effect of vitamin C on scurvy, Russo is currently pioneering research into one of the least understood, but probably most important, superfoods on the planet. One significant difference in their research? Oranges and limes aren’t a Schedule 1 narcotic that can get you thrown in jail for years.
That legal status has been a serious impediment to proper research on cannabis’s nutritional and medicinal value, but it hasn’t stopped other physicians from picking up on Russo’s lead.
An outspoken advocate for juicing raw cannabis leaves as a dietary supplement, Dr. William Courtney popularized the practice amongst growers in Northern California. Currently in the midst of setting up a juicing retreat center in the Caribbean, Courtney writes that “akin to Essential Fatty Acids and Essential Amino Acids, there needs to be Minimum Daily Requirements established to guide worldwide adoption of raw cannabis as the single most important dietary element.”
You can use cannabis much like any other vegetable.
While juicing raw cannabis is not psychoactive, it does allow for much of the plant’s medicinal benefits to be absorbed by the body. However, for many patients, sourcing an adequate amount of fresh cannabis leaves for juicing purposes can be troublesome. So Courtney and a growing chorus of other activists continue to agitate for the right to use cannabis in any amount necessary, much as any other vegetable.
Because along with its botanical cousin hemp, it seems that cannabis is a superfood in its own right, conferring superb health benefits, anti-inflammatory action and the power to prevent and treat diseases, along with many relaxing and rejuvenating qualities. In this sense, we can consider cannabis as another tool in our arsenal along with blue-green algae, maca, yacon, ginseng, cacao, matcha and other health-positive superfoods that help us reach our full, vibrant, active potential.
Fortunately, while all-too-many cannabis-infused edibles manufacturers continue to flood the market with sugary sweets, an increasing number of progressive companies recognize the plant’s unique medicinal benefits and have devoted themselves to creating cannabis-infused foods that combine cannabis with other superfood ingredients for maximum healing and supreme vitality.
Heather Hoffman from Pura Vida Health.
Heather Hoffman, co-founder and chief medical officer at Pura Vida Health, is a radiant young woman who studied holistic nutrition at the Canadian Institute of Natural Nutrition. When meeting her, it’s hard to imagine that she struggled mightily with epilepsy throughout her youth, but the condition is currently non-existent.
“Since I tried cannabis, I have not had a seizure,” Hoffman told HIGH TIMES. “It’s been five years, and I consider myself cured.”
Pura Vida creates power bars and granolas that pair ganja with other healthful ingredients, including papaya extract, oats and almonds, a blend that Hoffman believes “helps the body better utilize cannabis.” Available in over 100 California dispensaries, Pura Vida products use coconut oil, which “acts as a platform for cannabis to help the body absorb it, so people report getting higher quicker and feeling more of an impact.”
Hoffman said that while it can be tough to get healthy options on the shelves of dispensaries, if “we want cannabis to be what it truly is—a healing medicine—then we have a responsibility to actually do that,” and greater education is necessary so patients understand that nutritious cannabis-infused foods exist.
“It’s best to not give cancer patients a chocolate bar,” she explained. “Corn syrup and sugars aren’t medicine.”
When using cannabis as medicine, especially for patients fighting cancer, it’s important to remember that sugar feeds cancerous growth. Items that eschew refined sweeteners and processed ingredients in favor of combining cannabis with other nutrient-dense whole foods, additional herbs and supplements create functional edibles designed to promote specific effects like “energy boost” or “super sleep.”
It’s a viewpoint shared by Ezra Malmuth, founder of the Sababa Snacks Collective and also a graduate of the culinary nutrition program at Johnson & Wales University. While assisting a friend’s father who was suffering from stage 4 cancer, Malmuth found that a lot of the cannabis edibles he was eating “were not health conscious, had a lot of sugar and calories and didn’t taste great.” Determined to find a better way, Malmuth began combining superfood ingredients into “clusters,” small, bite-size morsels of dried fruit, nuts, spices and herbs.
“It was like an oatmeal cookie meets a granola bar,” Malmuth explained. “And it was delicious while providing the medicine that he needed.”
Sababa Snacks went on to capture a second place award for their Caramel Cashew Apricot clusters at the 2016 Nor-Cal Cannabis Cup, a win Malmuth attributes to “people who understand the value of wholesome food being attracted to this product.”
When selecting ingredients to pair with the 25 milligram dose of THC per cluster, Malmuth chose to create “an inherent offering to the body,” mixing oats and nuts to provide protein and dried fruit to provide carbohydrates, making a combination of macro-nutrients that supports the metabolic process. Favored as an athletic recovery snack, these clusters help long-distance runners “eliminate the inflammatory response to exercise,” Malmuth said, “while optimizing performance.”
Joseph Winke, founder of Jambo Superfoods, has always treated cannabis as an essential vitamin, mixing it into new versions of traditional healing foods, such as the company’s bestselling “Daily Ritual,” a unique blend of THC combined with medium chain triglyceride (MCT) oil and ghee from grass-fed cows. The resulting super-butter is meant to be enjoyed with morning coffee in the Bulletproof-style, or simply spread onto bread or used in cooking.
Winke champions the use of MCT oil, a type of coconut oil that is liquid at room temperature, explaining that this form of fat is especially bioavailable, so the “body is able to easily process these fats, so you get a really good uptake,” making the THC more effective.
“We use actual food that the body knows how to metabolize,” Winke explained. “Not high fructose corn syrup, artificial flavoring, or whey protein isolates…humans perform better when we have an abundance of cannabinoids.”
Much like how we perform better when we have vitamin C, antioxidants and essential amino acids available in our diets.
So remember, when we fight to free the cannabis plant, we’re fighting for our lives!
Related: 13 Healthy Cannabis Superfoods
For all of HIGH TIMES’ edibles coverage, click here.
from Medical Marijuana News http://ift.tt/2iMikva via https://www.potbox.com/
0 notes